Market Closed

ASND
Ascendis Pharma A/S
$ 275.39
3.12%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Ascendis Pharma A/S News

Latest Ascendis Pharma A/S Stock News & ASND Headlines

Ascendis Pharma A/S Q3 Earnings Call Highlights
3 days ago | marketbeat.com
Ascendis Pharma A/S (ASND) Q3 2026 Earnings Call Transcript
3 days ago | seekingalpha.com
Ascendis Pharma to Participate in the Jefferies London Healthcare Conference
5 days ago | globenewswire.com
Ascendis to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026
10 days ago | globenewswire.com
FDA Grants Priority Review to BridgeBio's Dwarfism Drug Filing
a month ago | zacks.com
Ascendis to Share Latest Advances in Hypoparathyroidism and Achondroplasia Programs at ASBMR 2026
a month ago | globenewswire.com
Ascendis Pharma A/S’s (ASND) “Overweight” Rating Reaffirmed at Cantor Fitzgerald
2 months ago | defenseworld.net
Ascendis Pharma A/S (ASND) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
2 months ago | seekingalpha.com
Why Is Ascendis Pharma Stock Trading Lower on Tuesday?
2 months ago | benzinga.com
Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases
2 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

ASND
Ascendis Pharma A/S
$ 275.39
3.12%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago